Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating income | -$1.61M | -$6.64M | -$14.5M | -$25.5M | -$45.0M | -$26.7M | -$29.7M |
| Net income | -$991K | -$5.46M | -$14.5M | -$25.3M | -$56.2M | -$24.6M | -$28.9M |
| EPS (diluted) | -$3.51 | -$0.87 | -$1.90 | -$3.10 | -$6.23 | -$2.31 | -$1.40 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$477K | -$3.97M | -$9.13M | -$17.3M | -$40.0M | -$21.9M | -$25.6M |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.86K | $8.07M | $45.7M | $28.4M | $5.75M | $10.6M | $19.5M |
| Total assets | $1.12M | $8.12M | $46.0M | $36.0M | $10.2M | $13.9M | $21.1M |
| Total liabilities | $2.62M | $578K | $1.51M | $7.70M | $18.0M | $4.62M | $4.23M |
| Shareholders' equity | -$8.58M | $7.54M | $44.5M | $28.3M | -$7.75M | $9.31M | $16.9M |
| Retained earnings | -$8.78M | -$14.2M | -$28.7M | -$54.1M | -$110M | -$135M | -$164M |
| Shares (wtd avg diluted) | 283K | 6.31M | 7.63M | 8.16M | 9.02M | 12.2M | 20.6M |
Every figure is extracted from Annovis Bio, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.